Ma XC - Search Results

1

Metabonomics: A Useful Tool to Reveal Underlying Relationships between Altered Chinese Medicine Syndromes and Ultrafiltration in Treatment of Heart Failure.

Guo LJ, Chen KJ, Sun MQ, Wang AZ, Gao F, Zheng Y, Ma XC. Guo LJ, et al. Among authors: ma xc. Chin J Integr Med. 2021 Apr;27(4):259-264. doi: 10.1007/s11655-020-3479-7. Epub 2021 Jan 9. Chin J Integr Med. 2021. PMID: 33420902

2

[Clinical study on effect of qingxin capsule in treating patients with hypertension of mild or moderate degree].

Lei Y, Lu QS, Ma XC, Chen KJ. Lei Y, et al. Among authors: ma xc. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Feb;25(2):114-8. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005. PMID: 15768872 Clinical Trial. Chinese.

3

A clinical study of Yigu capsule in treating postmenopausal osteoporosis.

Zhang RH, Chen KJ, Lu DX, Zhu XF, Ma XC. Zhang RH, et al. Among authors: ma xc. Chin J Integr Med. 2005 Jun;11(2):97-103. doi: 10.1007/BF02836464. Chin J Integr Med. 2005. PMID: 16150195 Clinical Trial.

4

[Clinical study on effect of qingxuan tiaoya recipe in treating menopausal women with hypertension].

Tao LL, Ma XC, Chen KJ. Tao LL, et al. Among authors: ma xc. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Aug;29(8):680-4. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009. PMID: 19848195 Clinical Trial. Chinese.

5

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).

Guo L, Yuan H, Zhang D, Zhang J, Hua Q, Ma X, Chen K. Guo L, et al. Medicine (Baltimore). 2020 May 22;99(21):e20271. doi: 10.1097/MD.0000000000020271. Medicine (Baltimore). 2020. PMID: 32481305 Free PMC article. Clinical Trial.

6

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

Wang A, Zhao W, Yan K, Huang P, Zhang H, Zhang Z, Zhang D, Ma X. Wang A, et al. Front Pharmacol. 2022 Feb 24;13:810587. doi: 10.3389/fphar.2022.810587. eCollection 2022. Front Pharmacol. 2022. PMID: 35281941 Free PMC article. Review.

7

Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.

Wang A, Zhao W, Yan K, Huang P, Zhang H, Ma X. Wang A, et al. Front Pharmacol. 2022 Apr 8;13:827770. doi: 10.3389/fphar.2022.827770. eCollection 2022. Front Pharmacol. 2022. PMID: 35462929 Free PMC article.

8

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Wang A, Li Z, Zhuo S, Gao F, Zhang H, Zhang Z, Ren G, Ma X. Wang A, et al. Front Cardiovasc Med. 2022 May 23;9:857952. doi: 10.3389/fcvm.2022.857952. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35677689 Free PMC article.

9

Guanxinning Injection Combined With Ischemic Postconditioning Attenuate Myocardial Ischemic Reperfusion Injury in Chronic Renal Failure Rats by Modulating Mitochondrial Dynamics.

Wang A, Zhang D, Liu J, Yan H, Zhang P, Yuan H, Ma X. Wang A, et al. Front Cardiovasc Med. 2022 May 30;9:905254. doi: 10.3389/fcvm.2022.905254. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35711377 Free PMC article.

10

[Evidence mapping of clinical research on 20 Chinese patent medicines for hypertension].

Wang YF, Guo LJ, Gao F, Zhang ZB, Ren GC, Ma XC. Wang YF, et al. Among authors: ma xc. Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(18):5097-5105. doi: 10.19540/j.cnki.cjcmm.20220602.501. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36164920 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters